Irinotecan-Induced Steatohepatitis: Current Insights
The hepatotoxicity of irinotecan is drawing wide concern nowadays due to the widespread use of this chemotherapeutic against various solid tumors, particularly metastatic colorectal cancer. Irinotecan-induced hepatotoxicity mainly manifests as transaminase increase and steatosis with or without tran...
Main Authors: | Jun Han, Jing Zhang, Chengliang Zhang |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-10-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2021.754891/full |
Similar Items
-
Chemotherapy-associated steatohepatitis
by: Lucy Meunier, et al.
Published: (2020-11-01) -
Steatosis and Steatohepatitis: Complex Disorders
by: Kira Bettermann, et al.
Published: (2014-06-01) -
Obesity-related non-alcoholic steatohepatitis and TGF-β1 serum levels in relation to morbid obesity
by: Ricardo N Sepúlveda-Flores, MD, et al.
Published: (2002-01-01) -
Non-alcoholic Steatohepatitis: An Overview
by: Allison Shifflet, et al.
Published: (2009-01-01) -
Herbal Medicines for Irinotecan-Induced Diarrhea
by: Liu Tang, et al.
Published: (2019-03-01)